nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Doxorubicin—stomach cancer	0.214	1	CrCtD
Epirubicin—Topoisomerase Inhibitors—Irinotecan—stomach cancer	0.12	0.407	CiPCiCtD
Epirubicin—Anthracyclines—Doxorubicin—stomach cancer	0.114	0.389	CiPCiCtD
Epirubicin—liver cancer—stomach cancer	0.0959	0.596	CtDrD
Epirubicin—pancreatic cancer—stomach cancer	0.0651	0.404	CtDrD
Epirubicin—Topoisomerase Inhibitors—Doxorubicin—stomach cancer	0.0598	0.203	CiPCiCtD
Epirubicin—Valrubicin—Doxorubicin—stomach cancer	0.0452	0.333	CrCrCtD
Epirubicin—Idarubicin—Doxorubicin—stomach cancer	0.0452	0.333	CrCrCtD
Epirubicin—Daunorubicin—Doxorubicin—stomach cancer	0.0452	0.333	CrCrCtD
Epirubicin—DHCR7—Doxorubicin—stomach cancer	0.0314	0.264	CbGbCtD
Epirubicin—YWHAG—Doxorubicin—stomach cancer	0.0314	0.264	CbGbCtD
Epirubicin—AURKA—Doxorubicin—stomach cancer	0.0314	0.264	CbGbCtD
Epirubicin—ABCC1—Irinotecan—stomach cancer	0.00647	0.0545	CbGbCtD
Epirubicin—TOP2A—Doxorubicin—stomach cancer	0.00637	0.0537	CbGbCtD
Epirubicin—ABCC1—Docetaxel—stomach cancer	0.00474	0.0399	CbGbCtD
Epirubicin—ABCC1—Doxorubicin—stomach cancer	0.00353	0.0298	CbGbCtD
Epirubicin—ABCC1—Methotrexate—stomach cancer	0.00342	0.0288	CbGbCtD
Epirubicin—CHD1—hematopoietic system—stomach cancer	0.000587	0.0525	CbGeAlD
Epirubicin—CHD1—pancreas—stomach cancer	0.000478	0.0427	CbGeAlD
Epirubicin—AURKA—hematopoietic system—stomach cancer	0.000473	0.0423	CbGeAlD
Epirubicin—CHD1—lymphoid tissue—stomach cancer	0.000413	0.0369	CbGeAlD
Epirubicin—DHCR7—hematopoietic system—stomach cancer	0.000396	0.0354	CbGeAlD
Epirubicin—CHD1—bone marrow—stomach cancer	0.000376	0.0336	CbGeAlD
Epirubicin—YWHAG—hematopoietic system—stomach cancer	0.000363	0.0325	CbGeAlD
Epirubicin—CHD1—Topotecan—Irinotecan—stomach cancer	0.000347	0.382	CbGdCrCtD
Epirubicin—CHD1—endocrine gland—stomach cancer	0.000337	0.0301	CbGeAlD
Epirubicin—AURKA—lymphoid tissue—stomach cancer	0.000333	0.0298	CbGeAlD
Epirubicin—AURKA—digestive system—stomach cancer	0.000329	0.0294	CbGeAlD
Epirubicin—DHCR7—pancreas—stomach cancer	0.000322	0.0288	CbGeAlD
Epirubicin—YWHAG—smooth muscle tissue—stomach cancer	0.00032	0.0286	CbGeAlD
Epirubicin—CHD1—liver—stomach cancer	0.000304	0.0272	CbGeAlD
Epirubicin—AURKA—bone marrow—stomach cancer	0.000303	0.0271	CbGeAlD
Epirubicin—YWHAG—pancreas—stomach cancer	0.000295	0.0264	CbGeAlD
Epirubicin—DHCR7—lymphoid tissue—stomach cancer	0.000278	0.0249	CbGeAlD
Epirubicin—DHCR7—digestive system—stomach cancer	0.000275	0.0246	CbGeAlD
Epirubicin—AURKA—endocrine gland—stomach cancer	0.000272	0.0243	CbGeAlD
Epirubicin—PLA2G4A—hematopoietic system—stomach cancer	0.000271	0.0242	CbGeAlD
Epirubicin—Doxorubicin—AKR1C3—stomach cancer	0.000257	0.613	CrCbGaD
Epirubicin—YWHAG—lymphoid tissue—stomach cancer	0.000255	0.0228	CbGeAlD
Epirubicin—DHCR7—bone marrow—stomach cancer	0.000254	0.0227	CbGeAlD
Epirubicin—YWHAG—digestive system—stomach cancer	0.000252	0.0226	CbGeAlD
Epirubicin—AURKA—liver—stomach cancer	0.000245	0.0219	CbGeAlD
Epirubicin—PLA2G4A—smooth muscle tissue—stomach cancer	0.000238	0.0213	CbGeAlD
Epirubicin—CHD1—lymph node—stomach cancer	0.000233	0.0208	CbGeAlD
Epirubicin—YWHAG—bone marrow—stomach cancer	0.000233	0.0208	CbGeAlD
Epirubicin—UGT2B7—digestive system—stomach cancer	0.000228	0.0204	CbGeAlD
Epirubicin—DHCR7—endocrine gland—stomach cancer	0.000227	0.0203	CbGeAlD
Epirubicin—YWHAG—endocrine gland—stomach cancer	0.000209	0.0186	CbGeAlD
Epirubicin—DHCR7—liver—stomach cancer	0.000205	0.0183	CbGeAlD
Epirubicin—UGT2B7—endocrine gland—stomach cancer	0.000188	0.0168	CbGeAlD
Epirubicin—YWHAG—liver—stomach cancer	0.000188	0.0168	CbGeAlD
Epirubicin—AURKA—lymph node—stomach cancer	0.000188	0.0168	CbGeAlD
Epirubicin—PLA2G4A—bone marrow—stomach cancer	0.000174	0.0155	CbGeAlD
Epirubicin—UGT2B7—liver—stomach cancer	0.00017	0.0152	CbGeAlD
Epirubicin—TOP2A—bone marrow—stomach cancer	0.000165	0.0147	CbGeAlD
Epirubicin—Doxorubicin—NOS3—stomach cancer	0.000163	0.387	CrCbGaD
Epirubicin—DHCR7—lymph node—stomach cancer	0.000157	0.014	CbGeAlD
Epirubicin—PLA2G4A—endocrine gland—stomach cancer	0.000156	0.0139	CbGeAlD
Epirubicin—YWHAG—lymph node—stomach cancer	0.000144	0.0129	CbGeAlD
Epirubicin—AURKA—Topotecan—Irinotecan—stomach cancer	0.000114	0.125	CbGdCrCtD
Epirubicin—PLA2G4A—lymph node—stomach cancer	0.000108	0.00962	CbGeAlD
Epirubicin—TOP2A—lymph node—stomach cancer	0.000102	0.00914	CbGeAlD
Epirubicin—ABCC1—liver—stomach cancer	8.02e-05	0.00717	CbGeAlD
Epirubicin—CHD1—Daunorubicin—Doxorubicin—stomach cancer	7.55e-05	0.083	CbGdCrCtD
Epirubicin—CHD1—Idarubicin—Doxorubicin—stomach cancer	7.55e-05	0.083	CbGdCrCtD
Epirubicin—PLA2G4A—Raltitrexed—Methotrexate—stomach cancer	7.24e-05	0.0796	CbGdCrCtD
Epirubicin—ABCC1—lymph node—stomach cancer	6.15e-05	0.0055	CbGeAlD
Epirubicin—AURKA—Cladribine—Floxuridine—stomach cancer	5.96e-05	0.0655	CbGdCrCtD
Epirubicin—TOP2A—Topotecan—Irinotecan—stomach cancer	4.36e-05	0.0479	CbGdCrCtD
Epirubicin—TOP2A—Paclitaxel—Docetaxel—stomach cancer	3.06e-05	0.0336	CbGdCrCtD
Epirubicin—AURKA—Daunorubicin—Doxorubicin—stomach cancer	2.48e-05	0.0273	CbGdCrCtD
Epirubicin—AURKA—Idarubicin—Doxorubicin—stomach cancer	2.48e-05	0.0273	CbGdCrCtD
Epirubicin—TOP2A—Cladribine—Floxuridine—stomach cancer	2.28e-05	0.025	CbGdCrCtD
Epirubicin—TOP2A—Daunorubicin—Doxorubicin—stomach cancer	9.49e-06	0.0104	CbGdCrCtD
Epirubicin—TOP2A—Idarubicin—Doxorubicin—stomach cancer	9.49e-06	0.0104	CbGdCrCtD
Epirubicin—Shock—Docetaxel—stomach cancer	6.95e-06	0.000153	CcSEcCtD
Epirubicin—Nervous system disorder—Docetaxel—stomach cancer	6.93e-06	0.000153	CcSEcCtD
Epirubicin—Pruritus—Fluorouracil—stomach cancer	6.93e-06	0.000153	CcSEcCtD
Epirubicin—Thrombocytopenia—Docetaxel—stomach cancer	6.92e-06	0.000153	CcSEcCtD
Epirubicin—Infestation—Doxorubicin—stomach cancer	6.92e-06	0.000153	CcSEcCtD
Epirubicin—Infestation NOS—Doxorubicin—stomach cancer	6.92e-06	0.000153	CcSEcCtD
Epirubicin—Drowsiness—Doxorubicin—stomach cancer	6.92e-06	0.000153	CcSEcCtD
Epirubicin—Visual impairment—Methotrexate—stomach cancer	6.91e-06	0.000153	CcSEcCtD
Epirubicin—Confusional state—Capecitabine—stomach cancer	6.9e-06	0.000152	CcSEcCtD
Epirubicin—Tachycardia—Docetaxel—stomach cancer	6.9e-06	0.000152	CcSEcCtD
Epirubicin—Skin disorder—Docetaxel—stomach cancer	6.86e-06	0.000152	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	6.86e-06	0.000151	CcSEcCtD
Epirubicin—Oedema—Capecitabine—stomach cancer	6.84e-06	0.000151	CcSEcCtD
Epirubicin—Renal failure—Doxorubicin—stomach cancer	6.8e-06	0.00015	CcSEcCtD
Epirubicin—Infection—Capecitabine—stomach cancer	6.8e-06	0.00015	CcSEcCtD
Epirubicin—Erythema multiforme—Methotrexate—stomach cancer	6.78e-06	0.00015	CcSEcCtD
Epirubicin—Neuropathy peripheral—Doxorubicin—stomach cancer	6.78e-06	0.00015	CcSEcCtD
Epirubicin—Dizziness—Irinotecan—stomach cancer	6.76e-06	0.000149	CcSEcCtD
Epirubicin—Jaundice—Doxorubicin—stomach cancer	6.74e-06	0.000149	CcSEcCtD
Epirubicin—Stomatitis—Doxorubicin—stomach cancer	6.74e-06	0.000149	CcSEcCtD
Epirubicin—Anorexia—Docetaxel—stomach cancer	6.74e-06	0.000149	CcSEcCtD
Epirubicin—Shock—Capecitabine—stomach cancer	6.73e-06	0.000149	CcSEcCtD
Epirubicin—Conjunctivitis—Doxorubicin—stomach cancer	6.72e-06	0.000148	CcSEcCtD
Epirubicin—Urinary tract infection—Doxorubicin—stomach cancer	6.72e-06	0.000148	CcSEcCtD
Epirubicin—Nervous system disorder—Capecitabine—stomach cancer	6.71e-06	0.000148	CcSEcCtD
Epirubicin—Eye disorder—Methotrexate—stomach cancer	6.7e-06	0.000148	CcSEcCtD
Epirubicin—Diarrhoea—Fluorouracil—stomach cancer	6.7e-06	0.000148	CcSEcCtD
Epirubicin—Thrombocytopenia—Capecitabine—stomach cancer	6.7e-06	0.000148	CcSEcCtD
Epirubicin—Tinnitus—Methotrexate—stomach cancer	6.68e-06	0.000148	CcSEcCtD
Epirubicin—Tachycardia—Capecitabine—stomach cancer	6.68e-06	0.000147	CcSEcCtD
Epirubicin—Cardiac disorder—Methotrexate—stomach cancer	6.65e-06	0.000147	CcSEcCtD
Epirubicin—Skin disorder—Capecitabine—stomach cancer	6.65e-06	0.000147	CcSEcCtD
Epirubicin—Sweating—Doxorubicin—stomach cancer	6.63e-06	0.000146	CcSEcCtD
Epirubicin—Hyperhidrosis—Capecitabine—stomach cancer	6.62e-06	0.000146	CcSEcCtD
Epirubicin—Hypotension—Docetaxel—stomach cancer	6.6e-06	0.000146	CcSEcCtD
Epirubicin—Haematuria—Doxorubicin—stomach cancer	6.59e-06	0.000146	CcSEcCtD
Epirubicin—Hepatobiliary disease—Doxorubicin—stomach cancer	6.54e-06	0.000144	CcSEcCtD
Epirubicin—Epistaxis—Doxorubicin—stomach cancer	6.52e-06	0.000144	CcSEcCtD
Epirubicin—Anorexia—Capecitabine—stomach cancer	6.52e-06	0.000144	CcSEcCtD
Epirubicin—Angiopathy—Methotrexate—stomach cancer	6.51e-06	0.000144	CcSEcCtD
Epirubicin—Vomiting—Irinotecan—stomach cancer	6.5e-06	0.000143	CcSEcCtD
Epirubicin—Sinusitis—Doxorubicin—stomach cancer	6.49e-06	0.000143	CcSEcCtD
Epirubicin—Immune system disorder—Methotrexate—stomach cancer	6.48e-06	0.000143	CcSEcCtD
Epirubicin—Dizziness—Fluorouracil—stomach cancer	6.48e-06	0.000143	CcSEcCtD
Epirubicin—Mediastinal disorder—Methotrexate—stomach cancer	6.46e-06	0.000143	CcSEcCtD
Epirubicin—Agranulocytosis—Doxorubicin—stomach cancer	6.45e-06	0.000142	CcSEcCtD
Epirubicin—Rash—Irinotecan—stomach cancer	6.45e-06	0.000142	CcSEcCtD
Epirubicin—Dermatitis—Irinotecan—stomach cancer	6.44e-06	0.000142	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Docetaxel—stomach cancer	6.44e-06	0.000142	CcSEcCtD
Epirubicin—Chills—Methotrexate—stomach cancer	6.43e-06	0.000142	CcSEcCtD
Epirubicin—Headache—Irinotecan—stomach cancer	6.4e-06	0.000141	CcSEcCtD
Epirubicin—Hypotension—Capecitabine—stomach cancer	6.39e-06	0.000141	CcSEcCtD
Epirubicin—Insomnia—Docetaxel—stomach cancer	6.39e-06	0.000141	CcSEcCtD
Epirubicin—Paraesthesia—Docetaxel—stomach cancer	6.35e-06	0.00014	CcSEcCtD
Epirubicin—Alopecia—Methotrexate—stomach cancer	6.34e-06	0.00014	CcSEcCtD
Epirubicin—Bradycardia—Doxorubicin—stomach cancer	6.32e-06	0.00014	CcSEcCtD
Epirubicin—Dyspnoea—Docetaxel—stomach cancer	6.3e-06	0.000139	CcSEcCtD
Epirubicin—Somnolence—Docetaxel—stomach cancer	6.28e-06	0.000139	CcSEcCtD
Epirubicin—Mental disorder—Methotrexate—stomach cancer	6.28e-06	0.000139	CcSEcCtD
Epirubicin—Malnutrition—Methotrexate—stomach cancer	6.24e-06	0.000138	CcSEcCtD
Epirubicin—Erythema—Methotrexate—stomach cancer	6.24e-06	0.000138	CcSEcCtD
Epirubicin—Haemoglobin—Doxorubicin—stomach cancer	6.24e-06	0.000138	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Capecitabine—stomach cancer	6.23e-06	0.000138	CcSEcCtD
Epirubicin—Vomiting—Fluorouracil—stomach cancer	6.23e-06	0.000137	CcSEcCtD
Epirubicin—Rhinitis—Doxorubicin—stomach cancer	6.22e-06	0.000137	CcSEcCtD
Epirubicin—Dyspepsia—Docetaxel—stomach cancer	6.22e-06	0.000137	CcSEcCtD
Epirubicin—Hepatitis—Doxorubicin—stomach cancer	6.21e-06	0.000137	CcSEcCtD
Epirubicin—Haemorrhage—Doxorubicin—stomach cancer	6.21e-06	0.000137	CcSEcCtD
Epirubicin—Insomnia—Capecitabine—stomach cancer	6.19e-06	0.000137	CcSEcCtD
Epirubicin—Hypoaesthesia—Doxorubicin—stomach cancer	6.18e-06	0.000136	CcSEcCtD
Epirubicin—Rash—Fluorouracil—stomach cancer	6.17e-06	0.000136	CcSEcCtD
Epirubicin—Dermatitis—Fluorouracil—stomach cancer	6.17e-06	0.000136	CcSEcCtD
Epirubicin—Pharyngitis—Doxorubicin—stomach cancer	6.16e-06	0.000136	CcSEcCtD
Epirubicin—Paraesthesia—Capecitabine—stomach cancer	6.14e-06	0.000136	CcSEcCtD
Epirubicin—Decreased appetite—Docetaxel—stomach cancer	6.14e-06	0.000136	CcSEcCtD
Epirubicin—Headache—Fluorouracil—stomach cancer	6.13e-06	0.000135	CcSEcCtD
Epirubicin—Urinary tract disorder—Doxorubicin—stomach cancer	6.13e-06	0.000135	CcSEcCtD
Epirubicin—Oedema peripheral—Doxorubicin—stomach cancer	6.12e-06	0.000135	CcSEcCtD
Epirubicin—Dysgeusia—Methotrexate—stomach cancer	6.11e-06	0.000135	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Docetaxel—stomach cancer	6.1e-06	0.000135	CcSEcCtD
Epirubicin—Connective tissue disorder—Doxorubicin—stomach cancer	6.1e-06	0.000135	CcSEcCtD
Epirubicin—Dyspnoea—Capecitabine—stomach cancer	6.1e-06	0.000135	CcSEcCtD
Epirubicin—Fatigue—Docetaxel—stomach cancer	6.09e-06	0.000134	CcSEcCtD
Epirubicin—Urethral disorder—Doxorubicin—stomach cancer	6.09e-06	0.000134	CcSEcCtD
Epirubicin—Nausea—Irinotecan—stomach cancer	6.07e-06	0.000134	CcSEcCtD
Epirubicin—Pain—Docetaxel—stomach cancer	6.04e-06	0.000133	CcSEcCtD
Epirubicin—Constipation—Docetaxel—stomach cancer	6.04e-06	0.000133	CcSEcCtD
Epirubicin—Back pain—Methotrexate—stomach cancer	6.04e-06	0.000133	CcSEcCtD
Epirubicin—Dyspepsia—Capecitabine—stomach cancer	6.02e-06	0.000133	CcSEcCtD
Epirubicin—Visual impairment—Doxorubicin—stomach cancer	5.98e-06	0.000132	CcSEcCtD
Epirubicin—Decreased appetite—Capecitabine—stomach cancer	5.95e-06	0.000131	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Capecitabine—stomach cancer	5.91e-06	0.00013	CcSEcCtD
Epirubicin—Fatigue—Capecitabine—stomach cancer	5.9e-06	0.00013	CcSEcCtD
Epirubicin—Vision blurred—Methotrexate—stomach cancer	5.88e-06	0.00013	CcSEcCtD
Epirubicin—Erythema multiforme—Doxorubicin—stomach cancer	5.87e-06	0.00013	CcSEcCtD
Epirubicin—Pain—Capecitabine—stomach cancer	5.85e-06	0.000129	CcSEcCtD
Epirubicin—Constipation—Capecitabine—stomach cancer	5.85e-06	0.000129	CcSEcCtD
Epirubicin—Feeling abnormal—Docetaxel—stomach cancer	5.82e-06	0.000129	CcSEcCtD
Epirubicin—Nausea—Fluorouracil—stomach cancer	5.82e-06	0.000128	CcSEcCtD
Epirubicin—Eye disorder—Doxorubicin—stomach cancer	5.8e-06	0.000128	CcSEcCtD
Epirubicin—Ill-defined disorder—Methotrexate—stomach cancer	5.79e-06	0.000128	CcSEcCtD
Epirubicin—Tinnitus—Doxorubicin—stomach cancer	5.79e-06	0.000128	CcSEcCtD
Epirubicin—Gastrointestinal pain—Docetaxel—stomach cancer	5.78e-06	0.000128	CcSEcCtD
Epirubicin—Anaemia—Methotrexate—stomach cancer	5.77e-06	0.000127	CcSEcCtD
Epirubicin—Cardiac disorder—Doxorubicin—stomach cancer	5.76e-06	0.000127	CcSEcCtD
Epirubicin—Flushing—Doxorubicin—stomach cancer	5.76e-06	0.000127	CcSEcCtD
Epirubicin—Feeling abnormal—Capecitabine—stomach cancer	5.64e-06	0.000124	CcSEcCtD
Epirubicin—Angiopathy—Doxorubicin—stomach cancer	5.63e-06	0.000124	CcSEcCtD
Epirubicin—Malaise—Methotrexate—stomach cancer	5.63e-06	0.000124	CcSEcCtD
Epirubicin—Immune system disorder—Doxorubicin—stomach cancer	5.61e-06	0.000124	CcSEcCtD
Epirubicin—Vertigo—Methotrexate—stomach cancer	5.61e-06	0.000124	CcSEcCtD
Epirubicin—Gastrointestinal pain—Capecitabine—stomach cancer	5.6e-06	0.000124	CcSEcCtD
Epirubicin—Mediastinal disorder—Doxorubicin—stomach cancer	5.6e-06	0.000124	CcSEcCtD
Epirubicin—Body temperature increased—Docetaxel—stomach cancer	5.59e-06	0.000123	CcSEcCtD
Epirubicin—Abdominal pain—Docetaxel—stomach cancer	5.59e-06	0.000123	CcSEcCtD
Epirubicin—Leukopenia—Methotrexate—stomach cancer	5.59e-06	0.000123	CcSEcCtD
Epirubicin—Chills—Doxorubicin—stomach cancer	5.57e-06	0.000123	CcSEcCtD
Epirubicin—Arrhythmia—Doxorubicin—stomach cancer	5.55e-06	0.000122	CcSEcCtD
Epirubicin—Alopecia—Doxorubicin—stomach cancer	5.49e-06	0.000121	CcSEcCtD
Epirubicin—Cough—Methotrexate—stomach cancer	5.45e-06	0.00012	CcSEcCtD
Epirubicin—Mental disorder—Doxorubicin—stomach cancer	5.44e-06	0.00012	CcSEcCtD
Epirubicin—Urticaria—Capecitabine—stomach cancer	5.44e-06	0.00012	CcSEcCtD
Epirubicin—Abdominal pain—Capecitabine—stomach cancer	5.41e-06	0.000119	CcSEcCtD
Epirubicin—Body temperature increased—Capecitabine—stomach cancer	5.41e-06	0.000119	CcSEcCtD
Epirubicin—Convulsion—Methotrexate—stomach cancer	5.41e-06	0.000119	CcSEcCtD
Epirubicin—Erythema—Doxorubicin—stomach cancer	5.4e-06	0.000119	CcSEcCtD
Epirubicin—Malnutrition—Doxorubicin—stomach cancer	5.4e-06	0.000119	CcSEcCtD
Epirubicin—Flatulence—Doxorubicin—stomach cancer	5.33e-06	0.000118	CcSEcCtD
Epirubicin—Myalgia—Methotrexate—stomach cancer	5.31e-06	0.000117	CcSEcCtD
Epirubicin—Arthralgia—Methotrexate—stomach cancer	5.31e-06	0.000117	CcSEcCtD
Epirubicin—Chest pain—Methotrexate—stomach cancer	5.31e-06	0.000117	CcSEcCtD
Epirubicin—Tension—Doxorubicin—stomach cancer	5.3e-06	0.000117	CcSEcCtD
Epirubicin—Dysgeusia—Doxorubicin—stomach cancer	5.29e-06	0.000117	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.28e-06	0.000116	CcSEcCtD
Epirubicin—Discomfort—Methotrexate—stomach cancer	5.25e-06	0.000116	CcSEcCtD
Epirubicin—Nervousness—Doxorubicin—stomach cancer	5.25e-06	0.000116	CcSEcCtD
Epirubicin—Back pain—Doxorubicin—stomach cancer	5.23e-06	0.000115	CcSEcCtD
Epirubicin—Hypersensitivity—Docetaxel—stomach cancer	5.21e-06	0.000115	CcSEcCtD
Epirubicin—Muscle spasms—Doxorubicin—stomach cancer	5.2e-06	0.000115	CcSEcCtD
Epirubicin—Confusional state—Methotrexate—stomach cancer	5.14e-06	0.000113	CcSEcCtD
Epirubicin—Anaphylactic shock—Methotrexate—stomach cancer	5.09e-06	0.000112	CcSEcCtD
Epirubicin—Vision blurred—Doxorubicin—stomach cancer	5.09e-06	0.000112	CcSEcCtD
Epirubicin—Asthenia—Docetaxel—stomach cancer	5.07e-06	0.000112	CcSEcCtD
Epirubicin—Infection—Methotrexate—stomach cancer	5.06e-06	0.000112	CcSEcCtD
Epirubicin—Hypersensitivity—Capecitabine—stomach cancer	5.04e-06	0.000111	CcSEcCtD
Epirubicin—Ill-defined disorder—Doxorubicin—stomach cancer	5.01e-06	0.000111	CcSEcCtD
Epirubicin—Pruritus—Docetaxel—stomach cancer	5e-06	0.00011	CcSEcCtD
Epirubicin—Nervous system disorder—Methotrexate—stomach cancer	5e-06	0.00011	CcSEcCtD
Epirubicin—Anaemia—Doxorubicin—stomach cancer	5e-06	0.00011	CcSEcCtD
Epirubicin—Thrombocytopenia—Methotrexate—stomach cancer	4.99e-06	0.00011	CcSEcCtD
Epirubicin—Agitation—Doxorubicin—stomach cancer	4.97e-06	0.00011	CcSEcCtD
Epirubicin—Skin disorder—Methotrexate—stomach cancer	4.95e-06	0.000109	CcSEcCtD
Epirubicin—Hyperhidrosis—Methotrexate—stomach cancer	4.92e-06	0.000109	CcSEcCtD
Epirubicin—Asthenia—Capecitabine—stomach cancer	4.91e-06	0.000108	CcSEcCtD
Epirubicin—Malaise—Doxorubicin—stomach cancer	4.87e-06	0.000108	CcSEcCtD
Epirubicin—Vertigo—Doxorubicin—stomach cancer	4.86e-06	0.000107	CcSEcCtD
Epirubicin—Anorexia—Methotrexate—stomach cancer	4.86e-06	0.000107	CcSEcCtD
Epirubicin—Syncope—Doxorubicin—stomach cancer	4.85e-06	0.000107	CcSEcCtD
Epirubicin—Pruritus—Capecitabine—stomach cancer	4.84e-06	0.000107	CcSEcCtD
Epirubicin—Leukopenia—Doxorubicin—stomach cancer	4.84e-06	0.000107	CcSEcCtD
Epirubicin—Diarrhoea—Docetaxel—stomach cancer	4.84e-06	0.000107	CcSEcCtD
Epirubicin—Palpitations—Doxorubicin—stomach cancer	4.78e-06	0.000105	CcSEcCtD
Epirubicin—Hypotension—Methotrexate—stomach cancer	4.76e-06	0.000105	CcSEcCtD
Epirubicin—Loss of consciousness—Doxorubicin—stomach cancer	4.75e-06	0.000105	CcSEcCtD
Epirubicin—Cough—Doxorubicin—stomach cancer	4.72e-06	0.000104	CcSEcCtD
Epirubicin—Convulsion—Doxorubicin—stomach cancer	4.68e-06	0.000103	CcSEcCtD
Epirubicin—Diarrhoea—Capecitabine—stomach cancer	4.68e-06	0.000103	CcSEcCtD
Epirubicin—Dizziness—Docetaxel—stomach cancer	4.67e-06	0.000103	CcSEcCtD
Epirubicin—Hypertension—Doxorubicin—stomach cancer	4.67e-06	0.000103	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.64e-06	0.000102	CcSEcCtD
Epirubicin—Insomnia—Methotrexate—stomach cancer	4.61e-06	0.000102	CcSEcCtD
Epirubicin—Myalgia—Doxorubicin—stomach cancer	4.6e-06	0.000102	CcSEcCtD
Epirubicin—Chest pain—Doxorubicin—stomach cancer	4.6e-06	0.000102	CcSEcCtD
Epirubicin—Arthralgia—Doxorubicin—stomach cancer	4.6e-06	0.000102	CcSEcCtD
Epirubicin—Anxiety—Doxorubicin—stomach cancer	4.59e-06	0.000101	CcSEcCtD
Epirubicin—Paraesthesia—Methotrexate—stomach cancer	4.57e-06	0.000101	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.57e-06	0.000101	CcSEcCtD
Epirubicin—Discomfort—Doxorubicin—stomach cancer	4.55e-06	0.0001	CcSEcCtD
Epirubicin—Dyspnoea—Methotrexate—stomach cancer	4.54e-06	0.0001	CcSEcCtD
Epirubicin—Somnolence—Methotrexate—stomach cancer	4.53e-06	0.0001	CcSEcCtD
Epirubicin—Dizziness—Capecitabine—stomach cancer	4.52e-06	9.99e-05	CcSEcCtD
Epirubicin—Dry mouth—Doxorubicin—stomach cancer	4.5e-06	9.93e-05	CcSEcCtD
Epirubicin—Vomiting—Docetaxel—stomach cancer	4.49e-06	9.92e-05	CcSEcCtD
Epirubicin—Dyspepsia—Methotrexate—stomach cancer	4.48e-06	9.9e-05	CcSEcCtD
Epirubicin—Rash—Docetaxel—stomach cancer	4.46e-06	9.84e-05	CcSEcCtD
Epirubicin—Dermatitis—Docetaxel—stomach cancer	4.45e-06	9.83e-05	CcSEcCtD
Epirubicin—Confusional state—Doxorubicin—stomach cancer	4.45e-06	9.82e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—UMPS—stomach cancer	4.44e-06	0.000229	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.44e-06	0.000229	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ANXA1—stomach cancer	4.43e-06	0.000229	CbGpPWpGaD
Epirubicin—Decreased appetite—Methotrexate—stomach cancer	4.43e-06	9.77e-05	CcSEcCtD
Epirubicin—Headache—Docetaxel—stomach cancer	4.43e-06	9.77e-05	CcSEcCtD
Epirubicin—Anaphylactic shock—Doxorubicin—stomach cancer	4.41e-06	9.74e-05	CcSEcCtD
Epirubicin—Oedema—Doxorubicin—stomach cancer	4.41e-06	9.74e-05	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.41e-06	0.000227	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MAPK1—stomach cancer	4.4e-06	0.000227	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Methotrexate—stomach cancer	4.4e-06	9.71e-05	CcSEcCtD
Epirubicin—Fatigue—Methotrexate—stomach cancer	4.39e-06	9.69e-05	CcSEcCtD
Epirubicin—Infection—Doxorubicin—stomach cancer	4.38e-06	9.67e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—CAV1—stomach cancer	4.37e-06	0.000225	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	4.36e-06	0.000225	CbGpPWpGaD
Epirubicin—Pain—Methotrexate—stomach cancer	4.36e-06	9.61e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—APOA1—stomach cancer	4.36e-06	0.000224	CbGpPWpGaD
Epirubicin—Vomiting—Capecitabine—stomach cancer	4.35e-06	9.6e-05	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—stomach cancer	4.34e-06	0.000224	CbGpPWpGaD
Epirubicin—Shock—Doxorubicin—stomach cancer	4.34e-06	9.58e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Doxorubicin—stomach cancer	4.33e-06	9.55e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—KISS1—stomach cancer	4.32e-06	0.000223	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RNF43—stomach cancer	4.32e-06	0.000223	CbGpPWpGaD
Epirubicin—Thrombocytopenia—Doxorubicin—stomach cancer	4.32e-06	9.53e-05	CcSEcCtD
Epirubicin—Rash—Capecitabine—stomach cancer	4.31e-06	9.52e-05	CcSEcCtD
Epirubicin—Dermatitis—Capecitabine—stomach cancer	4.31e-06	9.51e-05	CcSEcCtD
Epirubicin—Tachycardia—Doxorubicin—stomach cancer	4.3e-06	9.5e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ALDOB—stomach cancer	4.3e-06	0.000222	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRB1—stomach cancer	4.29e-06	0.000221	CbGpPWpGaD
Epirubicin—Headache—Capecitabine—stomach cancer	4.29e-06	9.46e-05	CcSEcCtD
Epirubicin—Skin disorder—Doxorubicin—stomach cancer	4.28e-06	9.46e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Doxorubicin—stomach cancer	4.26e-06	9.41e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CCND1—stomach cancer	4.25e-06	0.000219	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALDOB—stomach cancer	4.22e-06	0.000217	CbGpPWpGaD
Epirubicin—Anorexia—Doxorubicin—stomach cancer	4.2e-06	9.28e-05	CcSEcCtD
Epirubicin—Nausea—Docetaxel—stomach cancer	4.2e-06	9.27e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Methotrexate—stomach cancer	4.2e-06	9.27e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methotrexate—stomach cancer	4.17e-06	9.19e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—PRKCB—stomach cancer	4.16e-06	0.000214	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	4.15e-06	0.000214	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALB—stomach cancer	4.13e-06	0.000213	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PDHA1—stomach cancer	4.13e-06	0.000213	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ECHS1—stomach cancer	4.13e-06	0.000213	CbGpPWpGaD
Epirubicin—Hypotension—Doxorubicin—stomach cancer	4.12e-06	9.1e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—CDKN1A—stomach cancer	4.11e-06	0.000212	CbGpPWpGaD
Epirubicin—Nausea—Capecitabine—stomach cancer	4.06e-06	8.97e-05	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	4.05e-06	0.000209	CbGpPWpGaD
Epirubicin—Urticaria—Methotrexate—stomach cancer	4.05e-06	8.93e-05	CcSEcCtD
Epirubicin—Abdominal pain—Methotrexate—stomach cancer	4.03e-06	8.89e-05	CcSEcCtD
Epirubicin—Body temperature increased—Methotrexate—stomach cancer	4.03e-06	8.89e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—ALDOB—stomach cancer	4.02e-06	0.000207	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.02e-06	8.87e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ALOX5—stomach cancer	4e-06	0.000206	CbGpPWpGaD
Epirubicin—Insomnia—Doxorubicin—stomach cancer	3.99e-06	8.81e-05	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.98e-06	0.000205	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.97e-06	0.000205	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—stomach cancer	3.97e-06	0.000205	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.97e-06	0.000204	CbGpPWpGaD
Epirubicin—Paraesthesia—Doxorubicin—stomach cancer	3.96e-06	8.74e-05	CcSEcCtD
Epirubicin—DHCR7—Metabolism—NOS3—stomach cancer	3.95e-06	0.000204	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RPL15—stomach cancer	3.94e-06	0.000203	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—stomach cancer	3.93e-06	0.000203	CbGpPWpGaD
Epirubicin—Dyspnoea—Doxorubicin—stomach cancer	3.93e-06	8.68e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—DPYD—stomach cancer	3.93e-06	0.000203	CbGpPWpGaD
Epirubicin—Somnolence—Doxorubicin—stomach cancer	3.92e-06	8.66e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MAPK3—stomach cancer	3.92e-06	0.000202	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALOX5—stomach cancer	3.92e-06	0.000202	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.92e-06	0.000202	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TYMP—stomach cancer	3.88e-06	0.0002	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—FADS1—stomach cancer	3.88e-06	0.0002	CbGpPWpGaD
Epirubicin—Dyspepsia—Doxorubicin—stomach cancer	3.88e-06	8.57e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—NPM1—stomach cancer	3.87e-06	0.0002	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—DPYD—stomach cancer	3.86e-06	0.000199	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FST—stomach cancer	3.85e-06	0.000199	CbGpPWpGaD
Epirubicin—Decreased appetite—Doxorubicin—stomach cancer	3.83e-06	8.46e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—stomach cancer	3.81e-06	0.000196	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.81e-06	8.41e-05	CcSEcCtD
Epirubicin—Fatigue—Doxorubicin—stomach cancer	3.8e-06	8.39e-05	CcSEcCtD
Epirubicin—Pain—Doxorubicin—stomach cancer	3.77e-06	8.33e-05	CcSEcCtD
Epirubicin—Constipation—Doxorubicin—stomach cancer	3.77e-06	8.33e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—HBEGF—stomach cancer	3.77e-06	0.000194	CbGpPWpGaD
Epirubicin—Hypersensitivity—Methotrexate—stomach cancer	3.75e-06	8.28e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—RBP4—stomach cancer	3.74e-06	0.000193	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MAPK1—stomach cancer	3.73e-06	0.000192	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RGS2—stomach cancer	3.72e-06	0.000192	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GAST—stomach cancer	3.72e-06	0.000192	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—stomach cancer	3.69e-06	0.00019	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RPS26—stomach cancer	3.68e-06	0.00019	CbGpPWpGaD
Epirubicin—Asthenia—Methotrexate—stomach cancer	3.65e-06	8.07e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—PPIA—stomach cancer	3.65e-06	0.000188	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SREBF2—stomach cancer	3.64e-06	0.000187	CbGpPWpGaD
Epirubicin—Feeling abnormal—Doxorubicin—stomach cancer	3.63e-06	8.02e-05	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—stomach cancer	3.62e-06	0.000186	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Doxorubicin—stomach cancer	3.61e-06	7.96e-05	CcSEcCtD
Epirubicin—Pruritus—Methotrexate—stomach cancer	3.6e-06	7.95e-05	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	3.6e-06	0.000186	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—RORA—stomach cancer	3.59e-06	0.000185	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGG—stomach cancer	3.52e-06	0.000182	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—stomach cancer	3.52e-06	0.000181	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MAPK3—stomach cancer	3.5e-06	0.000181	CbGpPWpGaD
Epirubicin—Urticaria—Doxorubicin—stomach cancer	3.5e-06	7.73e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.49e-06	0.00018	CbGpPWpGaD
Epirubicin—Body temperature increased—Doxorubicin—stomach cancer	3.49e-06	7.7e-05	CcSEcCtD
Epirubicin—Abdominal pain—Doxorubicin—stomach cancer	3.49e-06	7.7e-05	CcSEcCtD
Epirubicin—Diarrhoea—Methotrexate—stomach cancer	3.49e-06	7.69e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—stomach cancer	3.48e-06	0.00018	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRB2—stomach cancer	3.48e-06	0.000179	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTT1—stomach cancer	3.48e-06	0.000179	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SERPINE1—stomach cancer	3.46e-06	0.000178	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—stomach cancer	3.45e-06	0.000178	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP2A6—stomach cancer	3.44e-06	0.000177	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PPP2R1A—stomach cancer	3.41e-06	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTT1—stomach cancer	3.41e-06	0.000176	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—stomach cancer	3.41e-06	0.000176	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKAA1—stomach cancer	3.39e-06	0.000175	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP2A6—stomach cancer	3.37e-06	0.000174	CbGpPWpGaD
Epirubicin—Dizziness—Methotrexate—stomach cancer	3.37e-06	7.43e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ALDOB—stomach cancer	3.37e-06	0.000174	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKR1C3—stomach cancer	3.34e-06	0.000172	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—RHOA—stomach cancer	3.34e-06	0.000172	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MAPK1—stomach cancer	3.33e-06	0.000172	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CCND1—stomach cancer	3.32e-06	0.000171	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS3—stomach cancer	3.3e-06	0.00017	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKR1C3—stomach cancer	3.28e-06	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RBP4—stomach cancer	3.28e-06	0.000169	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ENO1—stomach cancer	3.26e-06	0.000168	CbGpPWpGaD
Epirubicin—Hypersensitivity—Doxorubicin—stomach cancer	3.25e-06	7.17e-05	CcSEcCtD
Epirubicin—Vomiting—Methotrexate—stomach cancer	3.24e-06	7.15e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—stomach cancer	3.22e-06	0.000166	CbGpPWpGaD
Epirubicin—Rash—Methotrexate—stomach cancer	3.21e-06	7.09e-05	CcSEcCtD
Epirubicin—Dermatitis—Methotrexate—stomach cancer	3.21e-06	7.08e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ENO1—stomach cancer	3.19e-06	0.000165	CbGpPWpGaD
Epirubicin—Headache—Methotrexate—stomach cancer	3.19e-06	7.04e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.18e-06	0.000164	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.17e-06	0.000163	CbGpPWpGaD
Epirubicin—Asthenia—Doxorubicin—stomach cancer	3.16e-06	6.99e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.14e-06	0.000162	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALOX5—stomach cancer	3.13e-06	0.000161	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKR1C3—stomach cancer	3.13e-06	0.000161	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RPS19—stomach cancer	3.13e-06	0.000161	CbGpPWpGaD
Epirubicin—Pruritus—Doxorubicin—stomach cancer	3.12e-06	6.89e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CDKN1B—stomach cancer	3.12e-06	0.000161	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—DPYD—stomach cancer	3.08e-06	0.000159	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ENO1—stomach cancer	3.05e-06	0.000157	CbGpPWpGaD
Epirubicin—Nausea—Methotrexate—stomach cancer	3.03e-06	6.68e-05	CcSEcCtD
Epirubicin—Diarrhoea—Doxorubicin—stomach cancer	3.02e-06	6.66e-05	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.01e-06	0.000155	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—stomach cancer	2.97e-06	0.000153	CbGpPWpGaD
Epirubicin—Dizziness—Doxorubicin—stomach cancer	2.92e-06	6.44e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CD44—stomach cancer	2.89e-06	0.000149	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1A—stomach cancer	2.88e-06	0.000148	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CD44—stomach cancer	2.83e-06	0.000146	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HSPB1—stomach cancer	2.82e-06	0.000145	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGTR2—stomach cancer	2.82e-06	0.000145	CbGpPWpGaD
Epirubicin—Vomiting—Doxorubicin—stomach cancer	2.8e-06	6.19e-05	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TP53—stomach cancer	2.8e-06	0.000144	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.79e-06	0.000144	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2R—stomach cancer	2.79e-06	0.000144	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BMP2—stomach cancer	2.79e-06	0.000144	CbGpPWpGaD
Epirubicin—Rash—Doxorubicin—stomach cancer	2.78e-06	6.14e-05	CcSEcCtD
Epirubicin—Dermatitis—Doxorubicin—stomach cancer	2.78e-06	6.13e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—RPS6—stomach cancer	2.77e-06	0.000143	CbGpPWpGaD
Epirubicin—Headache—Doxorubicin—stomach cancer	2.76e-06	6.1e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.75e-06	0.000142	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—stomach cancer	2.74e-06	0.000141	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKR1C3—stomach cancer	2.74e-06	0.000141	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—stomach cancer	2.72e-06	0.00014	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR1A—stomach cancer	2.71e-06	0.00014	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD44—stomach cancer	2.7e-06	0.000139	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2A6—stomach cancer	2.69e-06	0.000139	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—stomach cancer	2.67e-06	0.000137	CbGpPWpGaD
Epirubicin—Nausea—Doxorubicin—stomach cancer	2.62e-06	5.78e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—ANXA1—stomach cancer	2.62e-06	0.000135	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKR1C3—stomach cancer	2.62e-06	0.000135	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—stomach cancer	2.61e-06	0.000134	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ENO1—stomach cancer	2.55e-06	0.000132	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HBEGF—stomach cancer	2.54e-06	0.000131	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB1—stomach cancer	2.54e-06	0.000131	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.51e-06	0.000129	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPP2R1A—stomach cancer	2.46e-06	0.000127	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK3—stomach cancer	2.45e-06	0.000126	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RPS6—stomach cancer	2.42e-06	0.000125	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTP1—stomach cancer	2.41e-06	0.000124	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPP2R1A—stomach cancer	2.41e-06	0.000124	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—stomach cancer	2.39e-06	0.000123	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCB—stomach cancer	2.38e-06	0.000123	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—stomach cancer	2.38e-06	0.000123	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—stomach cancer	2.38e-06	0.000123	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—stomach cancer	2.38e-06	0.000122	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6ST—stomach cancer	2.38e-06	0.000122	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTP1—stomach cancer	2.36e-06	0.000122	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK1—stomach cancer	2.33e-06	0.00012	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—stomach cancer	2.33e-06	0.00012	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PPP2R1A—stomach cancer	2.3e-06	0.000118	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CD44—stomach cancer	2.26e-06	0.000117	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MAPK3—stomach cancer	2.25e-06	0.000116	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TYMS—stomach cancer	2.24e-06	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HBEGF—stomach cancer	2.23e-06	0.000115	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—stomach cancer	2.22e-06	0.000115	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—stomach cancer	2.21e-06	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TYMS—stomach cancer	2.2e-06	0.000113	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.2e-06	0.000113	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—stomach cancer	2.17e-06	0.000112	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MAPK1—stomach cancer	2.14e-06	0.00011	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SMAD4—stomach cancer	2.13e-06	0.00011	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6R—stomach cancer	2.12e-06	0.000109	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ERCC2—stomach cancer	2.08e-06	0.000107	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB2—stomach cancer	2.06e-06	0.000106	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ERCC2—stomach cancer	2.04e-06	0.000105	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FYN—stomach cancer	2.03e-06	0.000104	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—KRAS—stomach cancer	2.02e-06	0.000104	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PPP2R1A—stomach cancer	2.01e-06	0.000104	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—stomach cancer	1.96e-06	0.000101	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—stomach cancer	1.96e-06	0.000101	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERCC2—stomach cancer	1.95e-06	0.0001	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPP2R1A—stomach cancer	1.92e-06	9.92e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—stomach cancer	1.92e-06	9.89e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RHOA—stomach cancer	1.91e-06	9.87e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGFR2—stomach cancer	1.9e-06	9.8e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTP1—stomach cancer	1.89e-06	9.73e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SMAD4—stomach cancer	1.87e-06	9.64e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—stomach cancer	1.86e-06	9.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—stomach cancer	1.86e-06	9.57e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—stomach cancer	1.83e-06	9.44e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAV1—stomach cancer	1.81e-06	9.3e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOA1—stomach cancer	1.8e-06	9.28e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—stomach cancer	1.8e-06	9.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FYN—stomach cancer	1.78e-06	9.15e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAV1—stomach cancer	1.77e-06	9.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOA1—stomach cancer	1.77e-06	9.1e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TYMS—stomach cancer	1.76e-06	9.05e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS2—stomach cancer	1.74e-06	8.98e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—stomach cancer	1.73e-06	8.94e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HRAS—stomach cancer	1.72e-06	8.86e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.69e-06	8.72e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CAV1—stomach cancer	1.69e-06	8.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOA1—stomach cancer	1.68e-06	8.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—stomach cancer	1.68e-06	8.66e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGFR2—stomach cancer	1.67e-06	8.59e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ERCC2—stomach cancer	1.63e-06	8.41e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6ST—stomach cancer	1.6e-06	8.25e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—stomach cancer	1.59e-06	8.18e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—stomach cancer	1.56e-06	8.02e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APC—stomach cancer	1.54e-06	7.93e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—stomach cancer	1.53e-06	7.9e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS2—stomach cancer	1.53e-06	7.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CAV1—stomach cancer	1.48e-06	7.63e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOA1—stomach cancer	1.48e-06	7.61e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6R—stomach cancer	1.43e-06	7.36e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—stomach cancer	1.43e-06	7.35e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAV1—stomach cancer	1.41e-06	7.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOA1—stomach cancer	1.41e-06	7.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCB—stomach cancer	1.41e-06	7.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6ST—stomach cancer	1.4e-06	7.23e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—stomach cancer	1.4e-06	7.21e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—stomach cancer	1.36e-06	7.03e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.35e-06	6.96e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APC—stomach cancer	1.35e-06	6.95e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—stomach cancer	1.34e-06	6.9e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—stomach cancer	1.34e-06	6.89e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK3—stomach cancer	1.29e-06	6.65e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RHOA—stomach cancer	1.29e-06	6.65e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—stomach cancer	1.28e-06	6.58e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6R—stomach cancer	1.25e-06	6.45e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—stomach cancer	1.25e-06	6.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—stomach cancer	1.24e-06	6.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK1—stomach cancer	1.23e-06	6.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—stomach cancer	1.23e-06	6.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—stomach cancer	1.22e-06	6.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB2—stomach cancer	1.19e-06	6.16e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—stomach cancer	1.17e-06	6.04e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—stomach cancer	1.17e-06	6.02e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KRAS—stomach cancer	1.16e-06	5.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RHOA—stomach cancer	1.13e-06	5.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—stomach cancer	1.12e-06	5.77e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—stomach cancer	1.12e-06	5.76e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1B—stomach cancer	1.11e-06	5.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—stomach cancer	1.07e-06	5.51e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—stomach cancer	1.07e-06	5.49e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB2—stomach cancer	1.05e-06	5.4e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1A—stomach cancer	1.02e-06	5.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—stomach cancer	9.93e-07	5.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—stomach cancer	9.86e-07	5.08e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—stomach cancer	9.78e-07	5.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1B—stomach cancer	9.69e-07	5e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—stomach cancer	9.44e-07	4.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—stomach cancer	9.25e-07	4.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JUN—stomach cancer	9.23e-07	4.76e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT3—stomach cancer	9.11e-07	4.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—stomach cancer	8.98e-07	4.63e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1A—stomach cancer	8.95e-07	4.61e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK8—stomach cancer	8.73e-07	4.5e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK3—stomach cancer	8.7e-07	4.49e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—stomach cancer	8.46e-07	4.36e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK1—stomach cancer	8.28e-07	4.27e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—stomach cancer	8.28e-07	4.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—stomach cancer	8.06e-07	4.16e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT3—stomach cancer	7.98e-07	4.11e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KRAS—stomach cancer	7.82e-07	4.03e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—stomach cancer	7.68e-07	3.96e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK3—stomach cancer	7.63e-07	3.93e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—stomach cancer	7.53e-07	3.88e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—stomach cancer	7.42e-07	3.82e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK1—stomach cancer	7.26e-07	3.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—stomach cancer	7.26e-07	3.74e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—stomach cancer	7.19e-07	3.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KRAS—stomach cancer	6.85e-07	3.53e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—stomach cancer	6.65e-07	3.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—stomach cancer	6.36e-07	3.28e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—stomach cancer	6.3e-07	3.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—stomach cancer	6.09e-07	3.14e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—stomach cancer	6.02e-07	3.1e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—stomach cancer	5.83e-07	3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—stomach cancer	5.58e-07	2.87e-05	CbGpPWpGaD
